RRM1 and amyotrophic lateral sclerosis: Recently, the use of both single-chain variable fragment (scFv) and monoclonal full-length antibody targeting the RRM1 domain of TDP-43 successfully attenuated TDP-43 proteinopathy in a genetic model of ALS induced by TDP-43A315T mutation [25,37].